Kathy Bowdish, PIC Therapeutics CEO
October 19, 2022 10:00 AM EDT
Financing
R&D

Backed by Or­biMed, Sanofi vet's start­up tack­les the many mu­ta­tions of breast can­cer at once

Lei Lei Wu

News Reporter

In Rata­touille, Re­my the rat con­trols a young cook from his chef’s hat, di­rect­ing his every move in the restau­rant kitchen and help­ing him make …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Q&A: Demis Has­s­abis talks win­ning the No­bel Prize, build­ing an AI biotech sans lab, and Trump’s po­ten­tial im­pact

Sarep­ta dis­con­tin­ues work on next-gen ex­on-skip­ping drug for Duchenne

Biotech in­dus­try wor­ries over po­ten­tial for RFK Jr. al­ly as FDA pick

Mod­er­na re­ports slow start to RSV sales as Ban­cel steps back from com­mer­cial role

Avid Bioser­vices to be sold to pri­vate eq­ui­ty firms for $1.1B

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times